• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Bruce Feinberg, DO, Speaks About Clinical Pathways in Oncology Care

Article

Bruce Feinberg, DO, Vice President and Chief Medical Officer, Cardinal Health Specialty Solutions, says that there is a tremendous amount of waste in the system.

Bruce Feinberg, DO, Vice President and Chief Medical Officer, Cardinal Health Specialty Solutions, says that there is a tremendous amount of waste in the system.

"Waste in the system is created by ineffective technology and claims processing that is very cumbersome for both payers and providers," says Dr Feinberg.

Related Videos
Dr Amrita Basu
Danielle Roman, PharmD, BCOP, Allgheny Health Network
Dr Eric Yang
Dr Adam Brufsky
Eleanor Perfetto, PhD
Paula Rodríguez-Otero, MD, PhD
Related Content
ICYMI: Highlights From Patient-Centered Oncology Care®

ICYMI: Highlights From Patient-Centered Oncology Care®

January 1st 2026
Article

Reader favorites from the 2025 Patient-Centered Oncology Care conference included articles and interviews featuring AI's role in precision medicine and the importance of collaboration in delivering care.

Read More

managed care cast logo

Switching From MA to TM Increases Mental Health Care Use: Angela Liu, PhD, MPH

December 23rd 2025
Podcast

Angela Liu, PhD, MPH, speaks about her study that examined mental health care use by Medicare beneficiaries before and after switching from MA to TM.

Listen

Explore AJMC’s top 5 obesity insights of 2025, covering GLP-1 therapy trends, access, costs, and strategies to improve patient care.

Top 5 Most-Read Obesity Content of 2025

December 30th 2025
Article

Our top 5 obesity articles of 2025 highlight GLP-1 prescribing trends, insurance coverage, co-pay caps, real-world use, and access challenges.

Read More

AJMC Managed Care Cast

AJMC® Editors Reflect on Milestone Year and Look to 2026

December 16th 2025
Podcast

The editors in chief of AJMC discuss the key managed care research and news from 2025 as the journal celebrated its 30th anniversary.

Listen

Advancing Treatment Options for Pediatric Myasthenia Gravis: A Q&A With Jonathan Strober, MD

Advancing Treatment Options for Pediatric Myasthenia Gravis: A Q&A With Jonathan Strober, MD

December 28th 2025
Article

Jonathan Strober, MD, discusses promising results from the VIBRANCE-MG trial, highlighting nipocalimab's safety and efficacy for pediatric myasthenia gravis.

Read More

The key takeaways from AAD 2025 include expert insights on topical JAK safety, climate-driven skin challenges, tech innovation, and expanding equitable access in dermatology.

ICYMI: Highlights From AAD 2025

December 25th 2025
Article

Here are our top highlights from AAD 2025 that include safety of topical JAK inhibitors, climate impacts on skin health, affordability of classic therapies, and advancing AI in dermatology.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.